Developing biosimilars of medicines that are due to come off patent could save the NHS up to £40m per year on average, a Medicines UK report has said
#ukpharmacy #biosimilar #offpatentmedicines
buff.ly/5Ewee4L
#ukpharmacy #biosimilar #offpatentmedicines
buff.ly/5Ewee4L
Supporting biosimilar development could unlock "massive demand", says trade body
Developing biosimilars of medicines that are due to come off patent could save the NHS up to £40m per year on average, a Medicines UK report has said. In its ‘UK biosimiliar void report’, published…
buff.ly
September 29, 2026 at 4:18 PM
Developing biosimilars of medicines that are due to come off patent could save the NHS up to £40m per year on average, a Medicines UK report has said
#ukpharmacy #biosimilar #offpatentmedicines
buff.ly/5Ewee4L
#ukpharmacy #biosimilar #offpatentmedicines
buff.ly/5Ewee4L